The purpose of this study is to determine whether a colonic tumor can be classified as malignant or benign with magnetic resonance (MR) colonography. Patients with a verified colon carcinoma or benign tumor based on diverticulitis are offered a MR colonography with intravenous (I.V.) contrast. The tumor is classified as malignant or benign by assessing the dynamic contrast uptake and morphology. The Investigator is blinded from the verified diagnosis and the MR classification is compared to the histological diagnosis.

Condition	Intervention	Phase
Colorectal Cancer Colorectal Tumor	Procedure: MR colonography with dynamic contrast uptake	Phase IV

Further Study Details: 

Primary Outcomes: Sensitivity in determining malignant or benign diagnose
Secondary Outcomes: Sensitivity/specificity of MR colonography
Expected Total Enrollment:  60

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

• Colorectal cancer
• Colorectal tumor

Exclusion Criteria:

• Active diverticulitis
• Pacemaker
• Metal in the body
• Claustrophobia

Please refer to this study by ClinicalTrials.gov identifier  NCT00114829

Michael P Achiam, M.D      +45 44884391    achiam1@dadlnet.dk

Denmark
      Department of Radiology Copenhagen University Hospital Herlev, Herlev,  Dk-.2730,  Denmark

Study chairs or principal investigators

Michael P Achiam, M.D.,  Principal Investigator,  Department of Radiology Copenhagen University Hospital Herlev   

Study ID Numbers:  KA05028-MA; KA05028
Record last reviewed:  May 2005
Last Updated:  June 30, 2005
Record first received:  June 17, 2005
ClinicalTrials.gov Identifier:  NCT00114829
Health Authority: Denmark: National Board of Health
ClinicalTrials.gov processed this record on 2005-07-05